Cristina Ponti

Entrectinib, a Pan–TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications

Elena Ardini, Maria Menichincheri, Patrizia Banfi et al. · Molecular Cancer Therapeutics · 2016 · 308 citations · Full text

The TPM3‐NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition

Elena Ardini, Roberta Bosotti, Andrea Borgia et al. · Molecular Oncology · 2014 · 151 citations · Full text

Trka Kinase Inhibition, Pathology, Cancer Biology +21

Role of HIF-1 and NF-κB Transcription Factors in the Modulation of Transferrin Receptor by Inflammatory and Anti-inflammatory Signals

Lorenza Tacchini, Elena Gammella, Cristina Ponti et al. · Journal of Biological Chemistry · 2008 · 127 citations · Full text

HIV‐1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFα activation

Davide Gibellini, Elisa De Crignis, Cristina Ponti et al. · Journal of Medical Virology · 2008 · 104 citations

Adenosine A2a receptor-mediated, normoxic induction of HIF-1 through PKC and PI-3K-dependent pathways in macrophages

Cristina Ponti, Rita Carini, Elisa Alchera et al. · Journal of Leukocyte Biology · 2007 · 75 citations